GB/T 16886.15-2022
ActiveBiological evaluation of medical devices—Part 15: Identification and quantification of degradation products from metals and alloys
医疗器械生物学评价 第15部分：金属与合金降解产物的定性与定量
Application Summary AI generated
This standard specifies methods for identifying and quantifying degradation products released from metallic and alloy components of medical devices under simulated physiological conditions. It is applied during biocompatibility testing and material characterization for implants, surgical instruments, and other long-term or short-term contact medical devices to assess potential toxicological risks from corrosion or wear. The standard ensures consistent evaluation of metal ion release, supporting regulatory compliance and patient safety in the medical device industry.
Related Standards
GB/T 19634-2005
In vitro diagnostic test systems-General technical requirements for blood-glucose monitoring systems for self-testing
GB/T 47486-2026
General technical requirements for vasculature-on-a-chip
GB/Z 30154-2013
Medical laboratories―Guidance on laboratory implementation of GB/T 22576-2008
GB/Z 16886.22-2022
Biological evaluation of medical devices—Part 22:Guidance on nanomaterials
GB/Z 43281-2023
Guidance for supervisors and operators of point-of-care testing(POCT) devices
GB/Z 43280-2023
Medical laboratories—Practical guidance for the estimation of measurement uncertainty
GB/Z 44363-2024
Pyrogenicity—Principles and methods for pyrogen testing of medical devices
GB/Z 157-2026
In vitro diagnostic test systems—Requirements and recommendations for detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by nucleic acid amplification methods
Transparency note: The application summary and key sentences on this page were automatically generated by AI from the standard's original text. This content has not been human-verified and should not be used for compliance or regulatory purposes. Always refer to the official standard document from the issuing authority.